Global Lipid Nanoparticle (LNP) Production Equipment Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Lipid Nanoparticle (LNP) Production Equipment market size was valued at US$ 71.3 million in 2024 and is forecast to a readjusted size of USD 362 million by 2031 with a CAGR of 27.4% during review period.
Lipid nanoparticles (LNPs) are the most advanced non viral gene delivery systems in clinical practice. Lipid nanoparticles can overcome a major obstacle in the development and application of genetic drugs, and safely and effectively transport nucleic acids. Gene drugs have many different application fields, such as gene editing, rapid vaccine development, tumor immunotherapy for rare genetic diseases and non drug-resistant diseases, and so on; All of these application areas are often hindered by low efficiency in nucleic acid delivery. LNP consists of four components: ionized lipid phospholipids, PEG lipids, cholesterol like structures, and lipids. These four components form a sphere with a diameter of about 100 nm, which can encapsulate mRNARNA i gene editing scissors and deliver them into the LNP sphere. The most critical component of LNP is ionized lipids, which are the key components for LNP to escape from its inner body. The new development of medicine has made drugs and their active ingredients increasingly complex and brought new challenges. For example, oligonucleotides are easily degraded in the human body. The latest research suggests that LNPs can form a stable environment for protecting active ingredients such as RNA, mRNA, siRNA, or DNA based APIs. The optimization of nucleic acid drugs and targeted cell delivery pathways is currently a very popular research field. Lipid nanoparticles (LNPs) are commonly used to encapsulate and deliver drugs such as mRNA. The LNP production equipment is used for the preparation and production of these lipid nanoparticles.
Since the discovery of the first generation of liposomes in the 1960s, lipid nanoparticle (LNPs) technology has made tremendous progress. Although the application scale of LNP in other fields such as medical imaging, cosmetics, nutrition, and agriculture is relatively small, it has significant development and application as a therapeutic carrier in the pharmaceutical industry. Lipid nanoparticles have been widely used in the pharmaceutical industry for decades. Compared with other gene and vaccine delivery systems, lipid nanoparticles are easier to mass produce, have lower immunogenicity, and can carry larger payloads - making them effective carriers for various drugs including small molecules, proteins, and nucleic acid drugs.
This report is a detailed and comprehensive analysis for global Lipid Nanoparticle (LNP) Production Equipment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Lipid Nanoparticle (LNP) Production Equipment market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global Lipid Nanoparticle (LNP) Production Equipment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global Lipid Nanoparticle (LNP) Production Equipment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global Lipid Nanoparticle (LNP) Production Equipment market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lipid Nanoparticle (LNP) Production Equipment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lipid Nanoparticle (LNP) Production Equipment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cytiva, Knauer, Micro&Nano Biologics, RainSure Scientific, Nanowetech (guangzhou) Instrument, Dolomite Microfluidics, Inside Therapeutics, Fluidiclab, Tofflon Science and Technology Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Lipid Nanoparticle (LNP) Production Equipment market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sample Volume<1L
Sample Volume1-10L
Sample Volume>10L
Market segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Major players covered
Cytiva
Knauer
Micro&Nano Biologics
RainSure Scientific
Nanowetech (guangzhou) Instrument
Dolomite Microfluidics
Inside Therapeutics
Fluidiclab
Tofflon Science and Technology Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lipid Nanoparticle (LNP) Production Equipment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lipid Nanoparticle (LNP) Production Equipment, with price, sales quantity, revenue, and global market share of Lipid Nanoparticle (LNP) Production Equipment from 2020 to 2025.
Chapter 3, the Lipid Nanoparticle (LNP) Production Equipment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lipid Nanoparticle (LNP) Production Equipment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Lipid Nanoparticle (LNP) Production Equipment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lipid Nanoparticle (LNP) Production Equipment.
Chapter 14 and 15, to describe Lipid Nanoparticle (LNP) Production Equipment sales channel, distributors, customers, research findings and conclusion.
Lipid nanoparticles (LNPs) are the most advanced non viral gene delivery systems in clinical practice. Lipid nanoparticles can overcome a major obstacle in the development and application of genetic drugs, and safely and effectively transport nucleic acids. Gene drugs have many different application fields, such as gene editing, rapid vaccine development, tumor immunotherapy for rare genetic diseases and non drug-resistant diseases, and so on; All of these application areas are often hindered by low efficiency in nucleic acid delivery. LNP consists of four components: ionized lipid phospholipids, PEG lipids, cholesterol like structures, and lipids. These four components form a sphere with a diameter of about 100 nm, which can encapsulate mRNARNA i gene editing scissors and deliver them into the LNP sphere. The most critical component of LNP is ionized lipids, which are the key components for LNP to escape from its inner body. The new development of medicine has made drugs and their active ingredients increasingly complex and brought new challenges. For example, oligonucleotides are easily degraded in the human body. The latest research suggests that LNPs can form a stable environment for protecting active ingredients such as RNA, mRNA, siRNA, or DNA based APIs. The optimization of nucleic acid drugs and targeted cell delivery pathways is currently a very popular research field. Lipid nanoparticles (LNPs) are commonly used to encapsulate and deliver drugs such as mRNA. The LNP production equipment is used for the preparation and production of these lipid nanoparticles.
Since the discovery of the first generation of liposomes in the 1960s, lipid nanoparticle (LNPs) technology has made tremendous progress. Although the application scale of LNP in other fields such as medical imaging, cosmetics, nutrition, and agriculture is relatively small, it has significant development and application as a therapeutic carrier in the pharmaceutical industry. Lipid nanoparticles have been widely used in the pharmaceutical industry for decades. Compared with other gene and vaccine delivery systems, lipid nanoparticles are easier to mass produce, have lower immunogenicity, and can carry larger payloads - making them effective carriers for various drugs including small molecules, proteins, and nucleic acid drugs.
This report is a detailed and comprehensive analysis for global Lipid Nanoparticle (LNP) Production Equipment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Lipid Nanoparticle (LNP) Production Equipment market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global Lipid Nanoparticle (LNP) Production Equipment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global Lipid Nanoparticle (LNP) Production Equipment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global Lipid Nanoparticle (LNP) Production Equipment market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lipid Nanoparticle (LNP) Production Equipment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lipid Nanoparticle (LNP) Production Equipment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cytiva, Knauer, Micro&Nano Biologics, RainSure Scientific, Nanowetech (guangzhou) Instrument, Dolomite Microfluidics, Inside Therapeutics, Fluidiclab, Tofflon Science and Technology Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Lipid Nanoparticle (LNP) Production Equipment market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Sample Volume<1L
Sample Volume1-10L
Sample Volume>10L
Market segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Major players covered
Cytiva
Knauer
Micro&Nano Biologics
RainSure Scientific
Nanowetech (guangzhou) Instrument
Dolomite Microfluidics
Inside Therapeutics
Fluidiclab
Tofflon Science and Technology Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lipid Nanoparticle (LNP) Production Equipment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lipid Nanoparticle (LNP) Production Equipment, with price, sales quantity, revenue, and global market share of Lipid Nanoparticle (LNP) Production Equipment from 2020 to 2025.
Chapter 3, the Lipid Nanoparticle (LNP) Production Equipment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lipid Nanoparticle (LNP) Production Equipment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Lipid Nanoparticle (LNP) Production Equipment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lipid Nanoparticle (LNP) Production Equipment.
Chapter 14 and 15, to describe Lipid Nanoparticle (LNP) Production Equipment sales channel, distributors, customers, research findings and conclusion.
Table of Contents
103 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Lipid Nanoparticle (LNP) Production Equipment by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
